William H. Carson - Net Worth and Insider Trading

William H. Carson Net Worth

The estimated net worth of William H. Carson is at least $78,976 dollars as of 2024-07-16. William H. Carson is the Director of Annexon Inc and owns about 12,800 shares of Annexon Inc (ANNX) stock worth over $78,976. Details can be seen in William H. Carson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William H. Carson has not made any transactions after 2024-07-01 and currently still holds the listed stock(s).

Transaction Summary of William H. Carson

To

William H. Carson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William H. Carson owns 3 companies in total, including Prevail Therapeutics Inc (PRVL) , Annexon Inc (ANNX) , and Decibel Therapeutics Inc (DBTX) .

Click here to see the complete history of William H. Carson’s form 4 insider trades.

Insider Ownership Summary of William H. Carson

Ticker Comapny Transaction Date Type of Owner
PRVL Prevail Therapeutics Inc 2020-09-09 director
ANNX Annexon Inc 2024-07-01 director
DBTX Decibel Therapeutics Inc 2021-06-02 director

William H. Carson Latest Holdings Summary

William H. Carson currently owns a total of 1 stock. William H. Carson owns 12,800 shares of Annexon Inc (ANNX) as of July 1, 2024, with a value of $78,976.

Latest Holdings of William H. Carson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANNX Annexon Inc 2024-07-01 12,800 6.17 78,976

Holding Weightings of William H. Carson


William H. Carson Form 4 Trading Tracker

According to the SEC Form 4 filings, William H. Carson has made a total of 4 transactions in Annexon Inc (ANNX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Annexon Inc is the acquisition of 3,200 shares on July 1, 2024, which cost William H. Carson around $16,000.

Insider Trading History of William H. Carson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William H. Carson Trading Performance

GuruFocus tracks the stock performance after each of William H. Carson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William H. Carson is -20.99%. GuruFocus also compares William H. Carson's trading performance to market benchmark return within the same time period. The performance of stocks bought by William H. Carson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William H. Carson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William H. Carson

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.6 LIMIT LIMIT LIMIT LIMIT LIMIT

William H. Carson Ownership Network

Ownership Network List of William H. Carson

No Data

Ownership Network Relation of William H. Carson

Insider Network Chart

William H. Carson Owned Company Details

What does Prevail Therapeutics Inc do?

Who are the key executives at Prevail Therapeutics Inc?

William H. Carson is the director of Prevail Therapeutics Inc. Other key executives at Prevail Therapeutics Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Peter A. Thompson , and General Counsel Kira M. Schwartz .

Prevail Therapeutics Inc (PRVL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Prevail Therapeutics Inc Insider Transactions

No Available Data

William H. Carson Mailing Address

Above is the net worth, insider trading, and ownership report for William H. Carson. You might contact William H. Carson via mailing address: C/o Prevail Therapeutics Inc., 430 East 29th Street, Suite 1520, New York Ny 10016.

Discussions on William H. Carson

No discussions yet.